{"id":"https://openalex.org/W4391214944","doi":"https://doi.org/10.1158/1541-7786.c.6539989","title":"Data from Targeting mTORC1\u2013Mediated Metabolic Addiction Overcomes Fludarabine Resistance in Malignant B Cells","display_name":"Data from Targeting mTORC1\u2013Mediated Metabolic Addiction Overcomes Fludarabine Resistance in Malignant B Cells","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4391214944","doi":"https://doi.org/10.1158/1541-7786.c.6539989"},"language":"en","primary_location":{"id":"doi:10.1158/1541-7786.c.6539989","doi":"https://doi.org/10.1158/1541-7786.c.6539989","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6539989","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"other","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1541-7786.c.6539989","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5016054222","display_name":"Arishya Sharma","orcid":"https://orcid.org/0000-0003-2309-3791","observed_orcids":["https://orcid.org/0000-0003-2309-3791"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Arishya Sharma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104110056","display_name":"Allison J. Janocha","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Allison J. Janocha","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006235077","display_name":"Brian Thomas Hill","orcid":"https://orcid.org/0000-0001-8781-3327","observed_orcids":["https://orcid.org/0000-0001-8781-3327"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian T. Hill","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089854184","display_name":"Mitchell Reed Smith","orcid":"https://orcid.org/0000-0003-1428-8765","observed_orcids":["https://orcid.org/0000-0003-1428-8765"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Mitchell R. Smith","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025638434","display_name":"SERPIL CEM ERZURUM","orcid":"https://orcid.org/0000-0001-5202-9065","observed_orcids":["https://orcid.org/0000-0001-5202-9065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Serpil C. Erzurum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5090436641","display_name":"Alexandru Almasan","orcid":"https://orcid.org/0000-0002-8916-6650","observed_orcids":["https://orcid.org/0000-0002-8916-6650"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alexandru Almasan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.7651000022888184,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.7651000022888184,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.22630000114440918,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12827","display_name":"Biochemical and Molecular Research","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/mtorc1","display_name":"mTORC1","score":0.9089999794960022},{"id":"https://openalex.org/keywords/fludarabine-resistance","display_name":"fludarabine resistance","score":0.9810000061988831},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.9940000176429749},{"id":"https://openalex.org/keywords/b-cells","display_name":"B cells","score":0.7059999704360962},{"id":"https://openalex.org/keywords/p70s6k","display_name":"p70S6K","score":0.9129999876022339},{"id":"https://openalex.org/keywords/p70-s6-kinase","display_name":"p70 S6 kinase","score":0.847000002861023},{"id":"https://openalex.org/keywords/pyrimidine-biosynthesis","display_name":"pyrimidine synthesis","score":0.8560000061988831},{"id":"https://openalex.org/keywords/dihydroorotate-dehydrogenase","display_name":"dihydroorotate dehydrogenase","score":0.8960000276565552},{"id":"https://openalex.org/keywords/aspartate-transcarbamoylase","display_name":"aspartate transcarbamylase","score":0.9020000100135803},{"id":"https://openalex.org/keywords/mitochondrial-respiration","display_name":"mitochondrial respiration","score":0.8009999990463257},{"id":"https://openalex.org/keywords/glycolysis","display_name":"glycolysis","score":0.8080000281333923},{"id":"https://openalex.org/keywords/oxidative-phosphorylation","display_name":"oxidative phosphorylation","score":0.9919999837875366},{"id":"https://openalex.org/keywords/metabolic-reprogramming","display_name":"metabolic reprogramming","score":0.8669999837875366},{"id":"https://openalex.org/keywords/rapalogs","display_name":"rapalogs","score":0.7720000147819519},{"id":"https://openalex.org/keywords/everolimus","display_name":"everolimus","score":0.847000002861023},{"id":"https://openalex.org/keywords/leflunomide","display_name":"leflunomide","score":0.8849999904632568},{"id":"https://openalex.org/keywords/n-phosphonacetyl-l-aspartate","display_name":"N-(phosphonacetyl)-L-aspartate","score":0.9629999995231628}],"concepts":[{"id":"https://openalex.org/C98490376","wikidata":"https://www.wikidata.org/wiki/Q14876060","display_name":"mTORC1","level":4,"score":0.8545393347740173},{"id":"https://openalex.org/C2779263901","wikidata":"https://www.wikidata.org/wiki/Q185916","display_name":"Fludarabine","level":4,"score":0.6591225862503052},{"id":"https://openalex.org/C48856860","wikidata":"https://www.wikidata.org/wiki/Q12029","display_name":"Addiction","level":2,"score":0.5739557147026062},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4883729815483093},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.36849045753479004},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2667262554168701},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.20576226711273193},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1908586025238037},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.17445409297943115},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.13387587666511536},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.10813423991203308},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1042582094669342},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.0859481692314148}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1541-7786.c.6539989","doi":"https://doi.org/10.1158/1541-7786.c.6539989","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6539989","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1541-7786.c.6539989","doi":"https://doi.org/10.1158/1541-7786.c.6539989","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1541-7786.c.6539989","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9537000060081482,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2319475844","https://openalex.org/W7098650549","https://openalex.org/W7097910943","https://openalex.org/W2309550097","https://openalex.org/W4362483033","https://openalex.org/W2353538207","https://openalex.org/W7125585720","https://openalex.org/W2577333208","https://openalex.org/W7097707883","https://openalex.org/W2088207925"],"abstract_inverted_index":{"Abstract":[0],"MTOR":[1],"complex-1(mTORC1)":[2],"activation":[3,19,70],"occurs":[4],"frequently":[5],"in":[6,75,119,133,141,162,199,269],"cancers,":[7],"yet":[8],"clinical":[9],"efficacy":[10],"of":[11,16,20,31,78,95,102,175,204,215,219,266],"rapalogs":[12],"is":[13,27],"limited":[14],"because":[15],"the":[17,92,137,260],"associated":[18],"upstream":[21],"survival":[22],"pathways.":[23],"An":[24],"alternative":[25],"approach":[26],"to":[28,36,147,155,225],"inhibit":[29],"downstream":[30],"mTORC1;":[32],"therefore,":[33],"acquired":[34],"resistance":[35,74,243],"fludarabine":[37],"(Flu),":[38],"a":[39,76,234,270],"purine":[40],"analogue":[41],"and":[42,85,104,113,121,125,130,182,185,195,211,217,241,247],"antimetabolite":[43],"chemotherapy,":[44],"active":[45],"agent":[46],"for":[47,263],"chronic":[48],"lymphocytic":[49],"leukemia":[50],"(CLL)":[51],"was":[52,144],"investigated.":[53],"Elevated":[54],"phospho-p70S6K,":[55],"also":[56],"known":[57],"as":[58,252],"RPS6KB1":[59],"(ribosomal":[60],"protein":[61],"S6":[62],"kinase,":[63],"70kDa,":[64],"polypeptide":[65],"1)":[66],"(T389),":[67],"an":[68,156],"mTORC1":[69,167],"marker,":[71],"predicted":[72],"Flu":[73,242],"panel":[77],"B-cell":[79],"lines,":[80],"isogenic":[81],"Flu-resistant":[82],"(FluR)":[83],"derivatives,":[84],"primary":[86,122],"human":[87],"CLL":[88,123],"cells.":[89,110,135,201,230],"Consistent":[90],"with":[91],"anabolic":[93],"role":[94],"mTORC1,":[96],"FluR":[97,120,134,142,200],"cells":[98,143],"had":[99],"higher":[100,138,148,196],"rates":[101],"glycolysis":[103,129],"oxidative":[105,131,139],"phosphorylation":[106,132,140,174],"than":[107],"Flu-sensitive":[108],"(FluS)":[109],"Rapalogs":[111],"(everolimus":[112],"rapamycin)":[114],"induced":[115],"moderate":[116],"cell":[117],"death":[118],"cells,":[124],"everolimus":[126],"significantly":[127],"inhibited":[128],"Strikingly,":[136],"not":[145,228],"coupled":[146],"ATP":[149],"synthesis.":[150],"Instead,":[151],"it":[152],"contributed":[153],"primarily":[154],"essential,":[157],"dihydroorotate":[158],"dehydrogenase":[159],"catalyzed,":[160],"step":[161],"de":[163,205,248],"novo":[164,206,249],"pyrimidine":[165,169,207,250,267],"biosynthesis.":[166],"promotes":[168],"biosynthesis":[170,208,251,268],"by":[171],"p70S6":[172],"kinase\u2013mediated":[173],"CAD":[176],"(carbamoyl-phosphate":[177],"synthetase":[178],"2,":[179],"aspartate":[180],"transcarbamylase,":[181],"dihydroorotase;":[183],"Ser1859)":[184],"favors":[186],"S-phase":[187,197],"cell-cycle":[188],"progression.":[189],"We":[190],"found":[191],"increased":[192],"phospho-CAD":[193],"(S1859)":[194],"population":[198],"Pharmacological":[202],"inhibition":[203,218],"using":[209],"N-phosphonacetyl-l-aspartate":[210],"leflunomide,":[212],"RNAi-mediated":[213],"knockdown":[214],"p70S6K,":[216],"mitochondrial":[220,245],"respiration":[221,246],"were":[222],"selectively":[223],"cytotoxic":[224],"FluR,":[226],"but":[227],"FluS,":[229],"These":[231],"results":[232],"reveal":[233],"novel":[235],"link":[236],"between":[237],"mTORC1-mediated":[238],"metabolic":[239],"reprogramming":[240],"identifying":[244],"potential":[253],"therapeutic":[254],"targets.":[255],"Implications:":[256],"This":[257],"study":[258],"provides":[259],"first":[261],"evidence":[262],"mTORC1/p70S6K-dependent":[264],"regulation":[265],"relevant":[271],"disease":[272],"setting.":[273],"Mol":[274],"Cancer":[275],"Res;":[276],"12(9);":[277],"1205\u201315.":[278],"\u00a92014":[279],"AACR.":[280]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2024-01-26T00:00:00"}